News

The PCI team never stops innovating. Stay informed about our latest achievements.

Growth of targeted therapies gives rise to need for flexible manufacturing of smaller API quantities

Tags: API Manufacturing | Blog | CDMO | Pharmaceutical Manufacturing | Scale-up

Posted July 20, 2018
This CDMO Deal Significant Sign Of The Times

Tags: Articles | Outsourced Pharma

Posted July 13, 2018
Providing Incentives to Attract Life Science Leaders to the State is Half the Battle

Tags: API Manufacturing | Blog | CDMO | MassBio | Medical device

Posted July 9, 2018
Ensuring Smooth Sailing When It Comes to FDA Inspections

Tags: API Manufacturing | Blog | CDMO | cGMP | FDA

Posted July 2, 2018
Novacap completes the acquisition of PCI Synthesis and expands its pharmaceutical offerings in the U.S.

Tags: Novacap | Press Releases

Posted June 28, 2018
Why Does the U.S. Continue to Lead the Contract Manufacturing Market?

Tags: API Manufacturing | Blog | Medical device

Posted June 22, 2018
5 Key Benefits as PCI Synthesis Gets Acquired

Tags: Blog | CDMO | Novacap

Posted June 20, 2018
Novacap to expand its pharmaceutical offering in the U.S. with the acquisition of PCI Synthesis

Tags: Novacap | Press Releases

Posted June 20, 2018
Top Mistakes in Analytical Method Validation and How to Avoid Them

Tags: Analytical Methods | API Manufacturing | Articles | Pharmaceutical Outsourcing

Posted June 12, 2018
Don’t Make These Mistakes in Your CDMO Master Services Agreement

Tags: Blog | CDMO | Managed Services Agreement

Posted June 4, 2018